Physician profile
William W Mcalexander
NPI 1073558524
$4,842.74
in general payments reported to CMS, 2019-2025
24 companies · $472 in 2025
The $472 reported for 2025 was less than what a typical Thoracic Surgery (Cardiothoracic Vascular Surgery) provider received nationally (typical 2025 total: $796).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,740 · 2020: $454 · 2021: $364 · 2022: $556 · 2023: $491 · 2024: $766 · 2025: $472.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,729.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,729.09 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Silk Road Medical, INC. | $1,326.24 | 2019-2023 | Enroute Transcarotid Neuroprotection System, Enroute Transcarotid Stent |
| Atricure, INC. | $863.36 | 2019-2025 | Atriclip Laa Exclusion System, Atricure Cryoice Cryosphere Cryoablation System, Synergy Ablation System |
| Edwards Lifesciences Corporation | $481.08 | 2020-2024 | Mitris Resilia Mitral Valve |
| Medtronic Vascular, INC. | $328.67 | 2019-2020 | |
| Angiodynamics, INC. | $223.98 | 2020-2021 | |
| Zimmer Biomet Holdings, INC. | $190.80 | 2023-2024 | Sternalock |
| Boston Scientific Corporation | $171.46 | 2019-2023 | Watchman Flx |
| Baxter Healthcare | $124.86 | 2022 | |
| Abbott Laboratories | $120.69 | 2025 | Navitor |
| Endologix LLC | $120.08 | 2019 | |
| Dilon Technologies, INC. | $112.89 | 2025 | Hemoblast Bellows |
| Artivion, INC. | $107.33 | 2024 | On-X Aortic Heart Valve With Conform-X Sewing Ring and Extended Holder, Bioglue Surgical Adhesive, Cardiac Non-Synergraft |
| Getinge USA Sales, LLC | $105.38 | 2023-2024 | Vasoview Hemopro 2, Heartstring III Proximal Seal |
| Cvrx, INC. | $102.21 | 2022-2024 | Barostim Neo System |
| Ethicon US, LLC | $93.77 | 2025 | Surgiflo Hemostatic Matrix, Vistaseal, Ethicon |
Show all 24 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Elutia, INC. | $84.88 | 2019 | |
| Abiomed | $67.54 | 2024 | |
| Intuitive Surgical, INC. | $54.05 | 2025 | |
| Biomerieux INC | $49.87 | 2019 | |
| Convatec INC. | $30.03 | 2024 | |
| Livanova USA, INC. | $29.01 | 2019 | |
| W. L. Gore & Associates, INC. | $21.15 | 2020 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $18.49 | 2025 | Lifevest |
| Medtronic USA, INC. | $14.92 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw William Mcalexander listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.